Announcement on Change of Sponsor Representative
Filed with SSE · · 2 pages · Chinese
Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Earlier from Shanghai Allist Pharmaceuticals
- Announcement on Voluntary Disclosure of Obtaining the Drug Clinical Trial Approval Notification for AST2303 Tablets
- Announcement on Attending Semi-annual Collective Performance Briefing 2024 for Pharmaceutical and Biological Products Companies on STAR Market
- Announcement on Signing Drug Technology License and Development Agreement with Jacobio
- Announcement on the Implementation of Semi-annual Dividend Distribution in 2024
- Semi-annual Report 2024
Later from Shanghai Allist Pharmaceuticals
- Report for Q3 2024
- Announcement on the Result of Shareholding Reduction by Shareholders and the Change in Equity Reaching 1%
- Announcement on Attending Collective Q3 Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2024
- Announcement on Accounting Firm Change
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
Follow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals